In this article, Baris Erdogan, PhD, together with Le Vin Chin, Editor-in-Chief and Marketing Director, share their experience in the Middle East regarding regulations and patient recruitment.
Read full article:
Summary:
The potential for the pharmaceuticals industry in the Middle East is vast, and growing. Clinical research is also growing, alongside pharma, in the region, despite variations in situation from country to country, and despite certain barriers that still need to be solved. The challenges of regulations and patient recruitment, in particular, are analysed. We take a specific look at one of the most established countries in the region for clinical trials, Turkey, to see how it might act as a model for the rest of the region.